Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunmax Biotechnology CoROCO:4728 -1.41%88 5-Year Yield-on-Cost % is 31.11 as of Aug. 11, 2026, which is 41% above its 10-year median of 22.11. GuruFocus rates ROCO:4728 with a GF Score™ of 88/100 and a GF Value™ of NT$344.92 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 150 Biotechnology companies, Sunmax Biotechnology Co ranks better than 98.67% on this metric.
The historical rank and industry rank for Sunmax Biotechnology Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:4728'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3 Med: 22.11 Max: 63.02
Current: 31.11
During the past 13 years, Sunmax Biotechnology Co's highest Yield on Cost was 63.02. The lowest was 3.00. And the median was 22.11.
ROCO:4728's 5-Year Yield-on-Cost % is ranked better than 98.67% of 150
companies
in the Biotechnology industry
Industry Median: 1.6
vs ROCO:4728: 31.11
Sunmax Biotechnology Co (ROCO:4728) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sunmax Biotechnology Co 5-Year Yield-on-Cost % Related Terms
ROCO:4728 vs VRTX, REGN, RVMD: 5-Year Yield-on-Cost % Comparison
For the Biotechnology subindustry, Sunmax Biotechnology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunmax Biotechnology Co 5-Year Yield-on-Cost % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sunmax Biotechnology Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sunmax Biotechnology Co's 5-Year Yield-on-Cost % falls into.
Sunmax Biotechnology Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Sunmax Biotechnology Co (ROCO:4728) has a 5-Year Yield-on-Cost % of 31.11 as of Aug. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sunmax Biotechnology Co and its competitors. This is 41% above median its historical median of 22.11. Over the past decade, Sunmax Biotechnology Co's 5-Year Yield-on-Cost % has ranged from 3.00 to 63.02. According to the industry distribution chart, Sunmax Biotechnology Co ranks #2 out of 150 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Sunmax Biotechnology Co's 5-Year Yield-on-Cost % too high?
Sunmax Biotechnology Co's current 5-Year Yield-on-Cost % of 31.11 is 41% above median its 10-year median of 22.11. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 63.02. The Biotechnology industry median 5-Year Yield-on-Cost % is 1.60. Sunmax Biotechnology Co's value of 31.11 is 1844.4% above this industry median. Based on the distribution chart, Sunmax Biotechnology Co ranks #2 out of 150 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sunmax Biotechnology Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sunmax Biotechnology Co's 5-Year Yield-on-Cost % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sunmax Biotechnology Co ranks #2 out of 150 companies for 5-Year Yield-on-Cost %. This places Sunmax Biotechnology Co in the top 1% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 1.60. Sunmax Biotechnology Co's value of 31.11 is 1844.4% above this benchmark. Historically, Sunmax Biotechnology Co's own 5-Year Yield-on-Cost % has ranged from 3.00 to 63.02 over the past decade. While the company's 10-year median is 22.11 vs. the industry median of 1.60, Sunmax Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Biotechnology company?
The median 5-Year Yield-on-Cost % among Biotechnology companies is 1.60, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunmax Biotechnology Co's current 5-Year Yield-on-Cost % of 31.11 is 1844.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sunmax Biotechnology Co and its competitors. For the Biotechnology industry, the median 5-Year Yield-on-Cost % is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunmax Biotechnology Co's current 5-Year Yield-on-Cost % is 31.11, which is 41% above median its own 10-year median of 22.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunmax Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sunmax Biotechnology Co (ROCO:4728) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$344.92, compared to a current price of NT$383.50 — trading 11.2% above its estimated fair value. The current 5-Year Yield-on-Cost % is 31.11, which is 41% above median its 10-year median of 22.11 and 1844.4% above the Biotechnology industry median of 1.60. Sunmax Biotechnology Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sunmax Biotechnology Co (ROCO:4728), the current 5-Year Yield-on-Cost % is 31.11 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunmax Biotechnology Co (ROCO:4728) Overvalued in 2026?
Based on GuruFocus' analysis, Sunmax Biotechnology Co stock appears to be overvalued.
The current stock price of NT$383.50 is trading 11.2% above its estimated GF Value™ of NT$344.92.
GuruFocus considers Sunmax Biotechnology Co to be Modestly Overvalued.
Key valuation signals for ROCO:4728:
5-Year Yield-on-Cost %: 31.11 (41% above median its 10-year median of 22.11)
GF Value™: NT$344.92 vs. price of NT$383.50 (11.2% above fair value)
Industry Position: 1844.4% above the Biotechnology median (#2 of 150)
No single metric tells the full story. See the ROCO:4728 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunmax Biotechnology Co Ltd is a biomedical company in Taiwan. It is engaged in the development, manufacturing, and commercialization of Sunmax medical devices and bio-surgical products. Additionally, it also researches, develops, manufactures and sales biomedical material grade collagen and related products. The company's products include medical products, biomedical materials, and porcine collagen skin care products.
88GF Score
Get the complete analysis for ROCO:4728
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4728 has been successfully added to your 
